BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 10771628)

  • 1. Serotonin discontinuation syndrome: does it really exist?
    Nuss S; Kincaid CR
    W V Med J; 2000; 96(2):405-7. PubMed ID: 10771628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressants in the postpartum period: additional considerations.
    Burbeck R; Pilling S; Tomson D; McDonald L
    Am J Psychiatry; 2008 Feb; 165(2):262-3; author reply 263. PubMed ID: 18245193
    [No Abstract]   [Full Text] [Related]  

  • 3. Dissecting dementia, depression, and drug effects in older adults.
    Sherrod RA; Collins A; Wynn S; Gragg M
    J Psychosoc Nurs Ment Health Serv; 2010 Jan; 48(1):39-47. PubMed ID: 20102132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant discontinuation: a review of the literature.
    Lejoyeux M; Adès J
    J Clin Psychiatry; 1997; 58 Suppl 7():11-5; discussion 16. PubMed ID: 9219488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Withdrawal symptoms in connection with the use of selective serotonin reuptake inhibitors (SSRI)].
    Gram LF
    Ugeskr Laeger; 1998 Dec; 160(50):7291-3. PubMed ID: 9859737
    [No Abstract]   [Full Text] [Related]  

  • 6. Neonatal symptoms following maternal paroxetine treatment: serotonin toxicity or paroxetine discontinuation syndrome?
    Haddad PM; Pal BR; Clarke P; Wieck A; Sridhiran S
    J Psychopharmacol; 2005 Sep; 19(5):554-7. PubMed ID: 16166193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discontinuation of antidepressant therapy: emerging complications and their relevance.
    Thompson C
    J Clin Psychiatry; 1998 Oct; 59(10):541-8. PubMed ID: 9818638
    [No Abstract]   [Full Text] [Related]  

  • 8. Olanzapine and serotonin toxicity.
    Isbister GK; Downes F; Whyte IM
    Psychiatry Clin Neurosci; 2003 Apr; 57(2):241-2. PubMed ID: 12667176
    [No Abstract]   [Full Text] [Related]  

  • 9. [Withdrawal syndrome after the use of serotonin reuptake inhibitors].
    Fagan M
    Tidsskr Nor Laegeforen; 2000 Mar; 120(8):913-4. PubMed ID: 10795494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors: a clinical investigation.
    Bogetto F; Bellino S; Revello RB; Patria L
    CNS Drugs; 2002; 16(4):273-83. PubMed ID: 11945110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Withdrawal syndrome associated with abrupt discontinuation of SSRIs.
    Wincor MZ
    J Am Pharm Assoc (Wash); 1998; 38(4):500-1. PubMed ID: 9707961
    [No Abstract]   [Full Text] [Related]  

  • 12. [SSRIs and other antidepressants discontinuation syndrome].
    Katsu H; Miyata H; Sannomiya M; Ushijima S
    Ryoikibetsu Shokogun Shirizu; 2003; (38):374-8. PubMed ID: 12877006
    [No Abstract]   [Full Text] [Related]  

  • 13. Adverse events after the abrupt discontinuation of paroxetine.
    Dominguez RA; Goodnick PJ
    Pharmacotherapy; 1995; 15(6):778-80. PubMed ID: 8602387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nocturnal enuresis after paroxetine abrupt discontinuation: a case report.
    Polimeni G; Grugno R; Cordici F; Vitetta A; Caputi AP; Bramanti P
    J Clin Psychopharmacol; 2008 Oct; 28(5):589-91. PubMed ID: 18794668
    [No Abstract]   [Full Text] [Related]  

  • 15. Recognition and treatment of serotonin syndrome.
    Frank C
    Can Fam Physician; 2008 Jul; 54(7):988-92. PubMed ID: 18625822
    [No Abstract]   [Full Text] [Related]  

  • 16. Serotonin Syndrome in Pregnancy.
    Roth CK; Hering SL; Campos S
    Nurs Womens Health; 2015; 19(4):345-9. PubMed ID: 26264799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Withdrawal syndromes after paroxetine and sertraline discontinuation.
    Fava GA; Grandi S
    J Clin Psychopharmacol; 1995 Oct; 15(5):374-5. PubMed ID: 8830071
    [No Abstract]   [Full Text] [Related]  

  • 18. Time to antidepressant discontinuation: a comparison of controlled-release paroxetine and immediate-release selective serotonin-reuptake inhibitors.
    Eaddy M; Bramley T; Regan T
    Manag Care Interface; 2003 Dec; 16(12):22-7. PubMed ID: 14750459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-treatment emergent adverse events in depressed patients following treatment with milnacipran and paroxetine.
    Vandel P; Sechter D; Weiller E; Pezous N; Cabanac F; Tournoux A; Panconi E
    Hum Psychopharmacol; 2004 Dec; 19(8):585-6. PubMed ID: 15570574
    [No Abstract]   [Full Text] [Related]  

  • 20. [The serotonin syndrome].
    Kozian R
    Psychiatr Prax; 2005 Oct; 32(7):367-9. PubMed ID: 16220422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.